🔎 Trials Near Me

홈 › 유방암 › 버지니아

버지니아의 유방암 임상 시험

유방암 관련 연구 76개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Inova Schar Cancer Institute, Fairfax
  • Virginia Cancer Specialists, PC, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06324357

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • Inova Schar Cancer Institute, Fairfax
  • Hampton University Proton Therapy Institute, Hampton
피험자 모집 중2상
50세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT01766297

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

  • Inova Schar Cancer Institute, Fairfax
피험자 모집 중3상
19세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05856773

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Bon Secours Virginia Health System, Midlothian
  • Virginia Oncology Associates, Norfolk
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05827081

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  • Virginia Oncology Associates (VOA) ( Site 8001), Norfolk
  • Shenandoah Oncology ( Site 8004), Winchester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, Charlottesville
  • Research Site, Fairfax
  • Research Site, Midlothian
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  • Inova Schar Cancer Institute ( Site 0025), Fairfax
  • Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian
  • VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian
  • Virginia Oncology Associates (VOA) ( Site 8008), Norfolk
  • Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8005), Roanoke
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  • Clinical Trial Site, Fort Belvoir
  • Clinical Trial Site, Midlothian
  • Clinical Trial Site, Norfolk
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Inova, Fairfax
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • University of Virginia Health System, Charlottesville
  • Inova Schar Cancer Institute, Fairfax
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07287098

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

  • Adult Outpatient Pavilion, Richmond
  • Cellular Immunotherapies and Transplant Department, Richmond
  • VCU Health at Stony Point, Richmond
피험자 모집 중
18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07426913

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

  • Next Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 여성 · 2026. 9. 21. 업데이트됨 · NCT07524855

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • NEXT Oncology, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  • Bon Secours Cancer Institute at Memorial Regional, Mechanicsville
  • Bon Secours St. Francis Medical Center, Midlothian
  • Bon Secours Cancer Institute at St. Mary's, Richmond
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Inova Schar Cancer Institute, Fairfax
  • Virginia Cancer Specialists, Fairfax
  • Virginia Oncology Associates, Newport News
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

  • Virginia Oncology Associates (VOA) ( Site 8001), Norfolk
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06797635

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Virginia Cancer Institute, Norfolk
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT05386108

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • NEXT Oncology, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06440005

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • NEXT Oncology - Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

  • Virginia Oncology Associates (Norfolk) - USOR, Norfolk
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07100106

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

  • Research Site, Midlothian
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07647328

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • Virginia Cancer Specialists-Fairfax, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07287917

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • Next Oncology, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Virginia Cancer Specialists, PC, Fairfax
  • Virginia Oncology Associates, Norfolk
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06982521

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Hematology-Oncology Associates of Fredericksburg, Inc, Fredericksburg
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Sentara Martha Jefferson Hospital, Charlottesville
  • Inova Schar Cancer Institute, Fairfax
  • Inova Fair Oaks Hospital, Fairfax
  • 외 5개
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Chesapeake Regional Medical Center, Chesapeake
  • Augusta Health Center for Cancer and Blood Disorders, Fishersville
  • Bon Secours Memorial Regional Medical Center, Mechanicsville
  • 외 7개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Kaiser Permanente-Burke Medical Center, Burke
  • University of Virginia Cancer Center, Charlottesville
  • Augusta Health Center for Cancer and Blood Disorders, Fishersville
  • 외 12개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07287995

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07029399

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07383506

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Virginia Cancer Specialists, Fairfax
  • Virginia Oncology Associates, Norfolk
  • Shenandoah Oncology, Winchester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07102381

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Inova Schar Cancer Institute, Falls Church
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06774963

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Inova Alexandria Hospital, Alexandria
  • Inova Schar Cancer Institute, Fairfax
  • Inova Fair Oaks Hospital, Fairfax
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.